- Published
- Updated
A noninferiority margin is not merely a technical input controlling sample size. It is a scientific decision defining an acceptable loss and determining how evidence about the active comparator is carried into the proposed comparison.
Define the question and assumptions
Assess clinical acceptability and historical evidence separately. Examine whether populations, comparator use and care conditions in previous studies match the new design. Margin justification cannot be separated from assumptions that the active comparator will provide an informative comparison in the proposed trial rather than an insensitive setting.
Hypothetical study example
In a hypothetical study, a wide margin is proposed to obtain an affordable sample. The team translates it into the loss allowed on the clinical scale. It seeks a scientific rationale rather than an easier success boundary and plans specialist regulatory discussion where appropriate for the development programme.
Design review checks
- Evaluate uncertainty and transferability of the historical evidence supporting the margin.
- Show the clinical meaning of the margin on the chosen effect scale.
- Plan assessment of adherence, missing follow-up and analysis-population implications.
Record the decision and its limits
An accepted record explains the selected margin and why alternatives were rejected. Statistical noninferiority does not establish exact equality or superiority. Poor adherence and missing data may make groups appear more similar, so conduct quality remains central to interpretation and relevant limitations must be reported transparently.
Frequently asked questions
- Can sample size convenience determine the margin?
- Feasibility alone cannot replace scientific and clinical justification.
- Does noninferiority mean equivalence?
- No. They involve different hypotheses and decision boundaries.